Transcatheter closure of large patent ductus arteriosus with severe pulmonary arterial hypertension in adults:immediate and two-year follow-up results

被引:0
|
作者
ZHANG Cao-jin [1 ]
HUANG Yi-gao [1 ]
HUANG Xin-sheng [1 ]
HUANG Tao [1 ]
HUANG Wen-hui [1 ]
XIA Chun-li [1 ]
MO Yu-jing [1 ]
机构
[1] Department of Cardiology,Guangdong General Hospital & Guangdong Cardiovascular Institute
关键词
D O I
暂无
中图分类号
R541.1 [先天性心脏血管病];
学科分类号
1002 ; 100201 ;
摘要
Background Transcatheter closure of patent ductus arteriosus(PDA) is a well established procedure and an accepted treatment modality for small to moderate-sized PDA.This study aimed to evaluate the immediate and follow-up results of transcatheter closure of large PDAs with severe pulmonary arterial hypertension(PAH) in adults. Methods After a complete hemodynamic evaluation differentiating from the reversibility of severe PAH,transcatheter closure of PDA was performed.Patients were followed up clinically and echocardiographically at 24 hours,1 month,3 months,6 months,12 months and 24 months after occlusion. Results Twenty-nine patients had successful occlusion,pulmonary artery pressure(PAP),left ventricular ejection fraction(LVEF) and fractional shortening(FS) significantly decreased immediately after occlusion((106±25) mmHg vs. (50±14) mmHg,P <0.01;(63.7±7.2)%vs.(51.4±10.1)%,P <0.01 and(36.9±8.2)%vs.(28.9+8.6)%,P <0.05, respectively).At 1 month after PDA closure,the signs and symptoms improved markedly in all 29 patients,and PDAs were completely closed and remained closed during the follow-up.Eighteen patients having different degrees of dyspnea were treated with angiotensin converting enzyme inhibitor(ACEI) and/or digoxin after occlusion.Nine patients whose pulmonary vascular resistence(PVR) >6 Wood units accepted targeted PAH therapy.After 1 to 3 months of peroral drug therapy,their exercise tolerance improved from New York Heart Association(NYHA) classⅢ-Ⅳto NYHA classⅠ.During follow-up,no latent arrhythmias were found,the left atrial diameter(LAD),left ventricular end-diastolic diameter(LVEDD), left ventricular end-systolic diameter(LVESD),left ventricular mass index(LVMI) and pulmonary artery systolic pressure (PASP) decreased significantly(P <0.05),and FS and LVEF recovered compared to the immediate postclosure state. However,FS and LVEF remained low compared to the preclosure state. Conclusions Transcatheter closure of large PDA with severe PAH is feasible,effective,and safe in adults.Significant left ventricular systolic changes may occur after closure of large PDA,and left ventricular function usually recovers within a few months.
引用
收藏
页码:3844 / 3850
相关论文
共 50 条
  • [41] Characteristics and prospective two-year follow-up of children with pulmonary arterial hypertension in France
    Fraisse, Alain
    Jais, Xavier
    Schleich, Jean-Marc
    Di Filippo, Sylvie
    Maragnes, Pascale
    Beghetti, Maurice
    Gressin, Virginie
    Voisin, Michel
    Dauphin, Claire
    Clerson, Pierre
    Godart, Francois
    Bonnet, Damien
    ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS, 2010, 2 (02) : 137 - 145
  • [42] Transcatheter Closure of Patent Ducts arteriosus with severe pulmonary-hypertension using domestic occlude in adults
    Han, Xiumin
    Zhu, Xianyang
    Zhang, Duanzhen
    CARDIOLOGY, 2013, 126 : 107 - 108
  • [43] Percutaneous device closure of patent ductus arteriosus in adult patients with 10-year follow-up
    Alkashkari, Wail
    Albugami, Saad
    Alrahimi, Jamilah
    Althobaiti, Mohammed
    Kinsara, Abdulhalim
    Abousa, Ahmed
    Krimly, Ahmed
    Alzahrani, Atif
    Niazi, Akram
    Aburemish, Hayam
    HEART VIEWS, 2019, 20 (04): : 139 - 145
  • [44] Percutaneous closure should be given a chance in patent ductus arteriosus with severe pulmonary hypertension
    Tepe, Omer
    Ozmen, Caglar
    Deniz, Ali
    Ozbarlas, Nazan
    Topcuoglu, Mehmet Sah
    CUKUROVA MEDICAL JOURNAL, 2020, 45 (02): : 758 - 759
  • [45] Transcatheter Closure of Patent Ductus Arteriosus in Elderly Patients: Initial and One-Year Follow-Up Results-Do We Have the Proper Device?
    Galeczka, Michal
    Szkutnik, Malgorzata
    Bialkowski, Jacek
    Smerdzinski, Sebastian
    Knop, Mateusz
    Sukiennik, Adam
    Fiszer, Roland
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2020, 2020
  • [46] A Challenging Interventional Procedure: Transcatheter Closure of Tubular Patent Ductus Arteriosus in Patients with Pulmonary Hypertension
    Yucel, Ilker Kemal
    Epcacan, Serdar
    Bulut, Mustafa Orhan
    Demir, Ibrahim Halil
    Surucu, Murat
    Yilmaz, Emine Hekim
    Kardas, Murat
    Kanlioglu, Pinar
    Celebi, Ahmet
    PEDIATRIC CARDIOLOGY, 2024, 45 (08) : 1636 - 1651
  • [47] Transcatheter closure of a large patent ductus arteriosus with severe pulmonary arterial hypertension in a childVerschluss eines großen persistierenden Ductus arteriosus mit schwerer pulmonaler Hypertonie über einen Katheter bei einem Kind
    C. Karakurt
    Ö. Elkıran
    S.F. Çelik
    G. Koçak
    Herz, 2013, 38 (6) : 685 - 688
  • [48] Transcatheter closure of large patent ductus arteriosus (>=4 mm) with multiple Gianturco coils: Immediate and mid-term results
    Hijazi, ZM
    Geggel, RL
    HEART, 1996, 76 (06) : 536 - 540
  • [49] Concurrent transcatheter closure of an apical muscular ventricular septal defect and a patent ductus arteriosus in a child with severe hyperkinetic pulmonary hypertension
    Joseph, G
    Muthunayagam, J
    Mandalay, A
    PEDIATRIC CARDIOLOGY, 2003, 24 (01) : 47 - 49
  • [50] Concurrent Transcatheter Closure of an Apical Muscular Ventricular Septal Defect and a Patent Ductus Arteriosus in a Child with Severe Hyperkinetic Pulmonary Hypertension
    G. Joseph
    J.V. Muthunayagam
    A. Mandalay
    Pediatric Cardiology, 2003, 24 : 47 - 49